Manipal Health Enterprises Limited has successfully completed the full redemption of ₹5,310 crore outstanding listed non-convertible debentures (NCDs) issued by its wholly owned subsidiary, Manipal Hospitals Private Limited. According to reports from The Hindu BusinessLine, ETHealthworld, and CNBC TV18, the redemption was executed using the relevant portion of IPO proceeds, in accordance with the objects of the initial public offering disclosed in the Prospectus dated July 31, 2026. The redemption includes the outstanding NCD principal, along with accrued interest and applicable prepayment/early redemption costs.
As reported by The Hindu BusinessLine, ETHealthworld, and CNBC TV18, this debt repayment represents a key milestone in the company's post-listing financial strategy and is expected to strengthen the balance sheet and improve financial leverage. Sameer Agarwal, Chief Financial Officer of Manipal Health Enterprises Limited, stated that the full redemption is an important milestone in their post-listing journey, as it strengthens the balance sheet, reduces interest burden, and creates greater financial headroom to support growth plans. The debt reduction is expected to support the company's focus on profitable growth and operational efficiency, while providing greater financial flexibility for ongoing expansion and investment priorities. According to CNBC TV18, this gives the company greater flexibility to continue investing in capacity, technology and talent while remaining focused on delivering quality and affordable healthcare.
According to The Hindu BusinessLine, ETHealthworld, and CNBC TV18, the company was listed on the markets on Wednesday, August 5, 2026. The IPO proceeds are actively being deployed to pay down debt accumulated from buying out clinical groups like Columbus Asia and Sahyadri Hospitals. The operator maintains an installed capacity of 13,140 beds across its network, making it the largest private healthcare network in the country by bed capacity. CNBC TV18 reports that the repayment forms part of Manipal Health's post-listing financial strategy and is aimed at reducing its debt and interest burden.
As reported by The Hindu BusinessLine and CNBC TV18, for Q1 FY27, Manipal Health posted strong financial results with revenue rising 38.1% year-on-year to ₹3,091 crore and EBITDA increasing 25.6% to ₹736.5 crore. However, the company's net profit declined 7.7% year-on-year to ₹231 crore compared with ₹250 crore in the corresponding quarter last year. The company's EBITDA margin narrowed to 23.8% from 26.2% a year earlier. Despite the profit decline, the strong revenue growth and improved EBITDA performance demonstrate robust operational performance following its market listing.
According to CNBC TV18, shares of Manipal Health Enterprises closed at ₹736.55, up 2.08% from its previous close on the National Stock Exchange, reflecting positive market sentiment following the debt repayment announcement. The market response indicates investor confidence in the company's strategic debt management and improved financial position.
